2020 Joint AAPM | COMP Virtual Meeting
Back to session list

Session Title: Point/Counterpoint: Most Pediatric Patients Should Be Treated at Proton Therapy Centers
Question 1: Which of the following statement for pediatric radiotherapy is incorrect?
Reference:1. Key statistics for childhood cancer on American Cancer Society website https://www.cancer.org/cancer/cancer-in-children/key-statistics.html 2. Hawkins M, Brownsdon A, Reulen R. Falling risk of heart disease among survivors of childhood cancer. BMJ 368:m58, 2020.
Choice A:On average, childhood cancer patients have over 80% of 5-year survival rate.
Choice B:Central nervous system tumors are the most common pediatric cancers treated with radiation therapy.
Choice C:Photon therapy is currently the most common modality in pediatric cancer radiotherapy.
Choice D:Treatment techniques for Hodgkin lymphoma have evolved from high dose and large fields to lower dose and more conformal fields.
Choice E:Risk of heart disease among survivors of childhood cancer has not seen any decline since 1970s despite technology advances.
Question 2: In pediatric intracranial treatments protons are significantly better than photons in
Reference:Carbonara R, Di Rito A, Monti A, Rubini G, Sardaro A. Proton versus Photon Radiotherapy for Pediatric Central Nervous System Malignancies: A Systematic Review and Meta-Analysis of Dosimetric Comparison Studies. J Oncol. 2019: PMID: 31885580
Choice A:Target dose conformity
Choice B:Target dose homogeneity and organ at risk dose reduction
Choice C:Achieving standard dose constraints
Choice D:All of the above
Question 3: What parameters impact the lateral penumbra of a proton beam?
Reference:Wang D, et al. Impact of spot size on plan quality of spot scanning proton radiosurgery for peripheral brain lesions. Med Phys 41(12): p12170, 2014.
Choice A:Energy
Choice B:Treatment depth
Choice C:Beam line configuration
Choice D:Beam aperture
Choice E:All of above
Question 4: The clinical studies that suggest protons are superior to photons for pediatric tumors are:
Reference:1. Kahalley LS, et al. Superior Intellectual outcomes after proton radiotherapy compared with photon radiotherapy for pediatric medulloblastoma. J Clin Oncol. 38:454-461, 2019. 2. Xiang M, Chang DG, Pollom EL. Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity modulated or proton beam radiation therapy. Cancer 000:1-3, 2020. doi:10.1002/cncr.32936
Choice A:Nonexistent
Choice B:Based exclusively on biological modeling
Choice C:Suggestive, but inconclusive
Choice D:Conclusive and unquestionable
Question 5: The rationale for treating children with protons:
Reference:Seravalli E, et al. Dosimetric comparison of five different techniques for craniospinal irradiation across 15 European Centers: Analysis on behalf of the SIOP-E-BTG (Radiotherapy working group). Acta Oncol 57: 1240-1249, 2018.
Choice A:Is inconsistent with radiation protection philosophy
Choice B:Is consistent with radiation protection philosophy
Choice C:Has nothing to do with radiation protection philosophy
Choice D:Is impossible because of radiation protection philosophy
Question 6: A valid consideration for whether proton plans will generally be better for pediatric patients than photon plans is:
Reference:Glimelius B, Montelius A. Proton beam therapy – Do we need the randomized trials and can we do them? Radiother Oncol 83:105–109, 2007.
Choice A:Protons always reduce the low dose volume which is known to benefit patients.
Choice B:Proton plans will benefit patients even if a photon plan can provide the required PTV coverage without exceeding tolerance doses.
Choice C:Proton plans may benefit the patient when photon plans exceed normal organ dose tolerances.
Choice D:Proton plans will dramatically reduce secondary malignancy risk over photon plans.
Back to session list